(Q54286036)

27 May 2018

title

Association of ErbB1-4 expression in invasive breast cancer with clinicopathological characteristics and prognosis. (English)

1 reference

27 May 2018

author name string

Saori Fujiwara

1

1 reference

27 May 2018

Mutsuko Ibusuki

2

1 reference

27 May 2018

Satoko Yamamoto

3

1 reference

27 May 2018

Yutaka Yamamoto

4

1 reference

27 May 2018

Hirotaka Iwase

5

1 reference

27 May 2018

publication date

26 October 2012

1 reference

27 May 2018

published in

Breast Cancer

1 reference

27 May 2018

volume

21

1 reference

27 May 2018

issue

4

1 reference

27 May 2018

page(s)

472-481

1 reference

27 May 2018

The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0415-5

Understanding the HER family in breast cancer: interaction with ligands, dimerization and treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0415-5

Epidermal growth factor receptor expression in breast cancer association with biologic phenotype and clinical outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0415-5

Epidermal growth factor receptor and vascular endothelial growth factor receptor 2 are specific biomarkers in triple-negative breast cancer. Results from a controlled randomized trial with long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0415-5

Clinical significance of basal-like subtype in triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0415-5

HER-3 overexpression is prognostic of reduced breast cancer survival: a study of 4046 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0415-5

Evaluation of the prognostic and predictive value of HER family mRNA expression in high-risk early breast cancer: a Hellenic Cooperative Oncology Group (HeCOG) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0415-5

Activation of ErbB3, EGFR and Erk is essential for growth of human breast cancer cell lines with acquired resistance to fulvestrant

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0415-5

Reactivation of epigenetically silenced HER4/ERBB4 results in apoptosis of breast tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0415-5

Cytogenetic analysis of HER1/EGFR, HER2, HER3 and HER4 in 278 breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0415-5

Integrated molecular profiles of invasive breast tumors and ductal carcinoma in situ (DCIS) reveal differential vascular and interleukin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0415-5

Immunohistochemical expression of epidermal growth factor receptor in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0415-5

Significance of epidermal growth factor receptor expression in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0415-5

Involvement of NF-κB/miR-448 regulatory feedback loop in chemotherapy-induced epithelial–mesenchymal transition of breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0415-5

Molecular characterization of breast cancer with high-resolution oligonucleotide comparative genomic hybridization array.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0415-5

Segmented regression, a versatile tool to analyze mRNA levels in relation to DNA copy number aberrations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0415-5

Integrated analysis of gene expression, CpG island methylation, and gene copy number in breast cancer cells by deep sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0415-5

Role of ErbB4 in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0415-5

The upgraded role of HER3 and HER4 receptors in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0415-5

A central role for HER3 in HER2-amplified breast cancer: implications for targeted therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0415-5

Transcriptional and posttranslational up-regulation of HER3 (ErbB3) compensates for inhibition of the HER2 tyrosine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0415-5

The ERalpha coactivator, HER4/4ICD, regulates progesterone receptor expression in normal and malignant breast epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0415-5

Coregulation of estrogen receptor by ERBB4/HER4 establishes a growth-promoting autocrine signal in breast tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0415-5

Wwox and Ap2gamma expression levels predict tamoxifen response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0415-5

The HER4/4ICD estrogen receptor coactivator and BH3-only protein is an effector of tamoxifen-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0415-5

A constitutively active ERBB4/HER4 allele with enhanced transcriptional coactivation and cell-killing activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-012-0415-5

10.1007/S12282-012-0415-5

21 January 2018

Identifiers

DOI

1 reference

27 May 2018

1 reference

27 May 2018